These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 18562234)
1. Rituximab as a treatment alternative in sarcoidosis. Belkhou A; Younsi R; El Bouchti I; El Hassani S Joint Bone Spine; 2008 Jul; 75(4):511-2. PubMed ID: 18562234 [No Abstract] [Full Text] [Related]
2. Rituximab in rheumatic diseases. Saraux A; Devauchelle V; Jousse S; Youinou P Joint Bone Spine; 2007 Jan; 74(1):4-6. PubMed ID: 17178461 [No Abstract] [Full Text] [Related]
3. Lack of short-term efficacy of rituximab upon symptoms of ankylosing spondylitis treated for an associated vasculitis. Wendling D; Augé B; Streit G; Toussirot E; Mathieu S Joint Bone Spine; 2008 Jul; 75(4):510-1. PubMed ID: 18457981 [No Abstract] [Full Text] [Related]
6. Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Nocturne G; Dougados M; Constantin A; Richez C; Sellam J; Simon A; Wendling D; Mariette X; Gottenberg JE Ann Rheum Dis; 2010 Feb; 69(2):471-2. PubMed ID: 20107035 [No Abstract] [Full Text] [Related]
7. Successful treatment of cardiac sarcoidosis with infliximab. Barnabe C; McMeekin J; Howarth A; Martin L J Rheumatol; 2008 Aug; 35(8):1686-7. PubMed ID: 18671332 [No Abstract] [Full Text] [Related]
8. Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al. Ramos-Casals M; Díaz-Lagares C; Khamashta MA Arthritis Rheum; 2009 Sep; 61(9):1281-2. PubMed ID: 19714598 [No Abstract] [Full Text] [Related]
9. Negative clinical trials in sarcoidosis: failed therapies or flawed study design? Moller DR Eur Respir J; 2014 Nov; 44(5):1123-6. PubMed ID: 25362122 [No Abstract] [Full Text] [Related]
11. Relapse of severe sarcoidosis with an uncommon peritoneal location after TNFalpha blockade. Efficacy of rituximab, report of a single case. Dasilva V; Breuil V; Chevallier P; Euller-Ziegler L Joint Bone Spine; 2010 Jan; 77(1):82-3. PubMed ID: 20022779 [No Abstract] [Full Text] [Related]
12. Potential biomarkers of monocyte/macrophage activity in a patient with sarcoidosis, treated with infliximab. Fang B; Bhagat S; Busch R; Parfrey H; Hall FC Rheumatology (Oxford); 2011 May; 50(5):992-4. PubMed ID: 21278065 [No Abstract] [Full Text] [Related]
13. Rituximab: a new therapeutic alternative in rheumatoid arthritis. Sibilia J; Gottenberg JE; Mariette X Joint Bone Spine; 2008 Oct; 75(5):526-32. PubMed ID: 18571968 [TBL] [Abstract][Full Text] [Related]
14. Tendency towards erosive regression on magnetic resonance imaging at 12 months in rheumatoid arthritis patients treated with rituximab. Døhn UM; Ostergaard M; Bird P; Boonen A; Johansen JS; Møller JM; Hansen MS Ann Rheum Dis; 2009 Jun; 68(6):1072-3. PubMed ID: 19435723 [No Abstract] [Full Text] [Related]
15. Efficacy of rituximab in Felty's syndrome. Shipley E; Héraud A; Hennette A; Vernhes JP Joint Bone Spine; 2008 Oct; 75(5):621-2. PubMed ID: 18805034 [No Abstract] [Full Text] [Related]
16. New and promising treatments for rheumatoid arthritis. Looney RJ; Stohl W Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):18-23. PubMed ID: 17694190 [No Abstract] [Full Text] [Related]
17. [Rituximab treatment of rheumatoid arthritis: new evidence]. Nasonov EL Ter Arkh; 2009; 81(6):82-91. PubMed ID: 19663200 [TBL] [Abstract][Full Text] [Related]
18. One case of Felty's syndrome efficiently treated with rituximab. Tomi AL; Lioté F; Ea HK Joint Bone Spine; 2012 Dec; 79(6):624-5. PubMed ID: 22401785 [TBL] [Abstract][Full Text] [Related]
19. B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience. Shaw T; Quan J; Totoritis MC Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii55-9. PubMed ID: 14532151 [No Abstract] [Full Text] [Related]